Orris

Typhoid

Reading File
Finding Sources
Finding Sources
Searching Images

typhoid fever Salmonella typhi rose spots rash

This clinical photograph shows an intraoperative view of an exploratory laparotomy, demonstrating a bowel perforation in the context of typhoid fever (Salmonella Typhi). The image focuses on a loop of small intestine held by a surgeon's gloved hands, revealing a discrete, longitudinal perforation with hyperemic and slightly everted edges. The surrounding serosa exhibits generalized inflammation and congestion. In the background, other segments of the intestine appear edematous and pale-pink, with visible white-yellowish peritoneal nodules and purulent exudate suggestive of concurrent miliary peritoneal tuberculosis and secondary peritonitis. Surgical instruments, suction tubing, and green sterile drapes define the surgical field. This image serves as an educational example of the severe gastrointestinal complications of typhoid fever, specifically intestinal perforation, and illustrates the challenging clinical scenario of co-infection with tuberculosis in an acute surgical setting.

This clinical photograph shows an intraoperative view of an exploratory laparotomy, demonstrating a bowel perforation in the context of typhoid fever (Salmonella Typhi). The image focuses on a loop of small intestine held by a surgeon's gloved hands, revealing a discrete, longitudinal perforation with hyperemic and slightly everted edges. The surrounding serosa exhibits generalized inflammation and congestion. In the background, other segments of the intestine appear edematous and pale-pink, with visible white-yellowish peritoneal nodules and purulent exudate suggestive of concurrent miliary peritoneal tuberculosis and secondary peritonitis. Surgical instruments, suction tubing, and green sterile drapes define the surgical field. This image serves as an educational example of the severe gastrointestinal complications of typhoid fever, specifically intestinal perforation, and illustrates the challenging clinical scenario of co-infection with tuberculosis in an acute surgical setting.

A diagnostic Western blot (WB) analysis image showing the immunoreactivity of antigens derived from Salmonella typhi and Salmonella spp. The image displays six experimental lanes representing three different protein extraction methods—Whole Cell Protein (WCP), Cell Surface Protein (CSP), and sodium deoxycholate-extracted WCP (sdWCP)—for each bacterial species. A molecular weight (MW) marker lane on the far left, stained with Ponceau S, shows reference bands from 40 kDa to 70 kDa. The WB profile is categorized into three vertical regions: R1 (≥ 55 kDa), R2 (54–34 kDa), and R3 (< 34 kDa). Prominent, high-intensity immunoreactive bands are observed in both species at approximately 70 kDa and 46 kDa, with a noticeable smear in the CSP lanes. Low molecular weight bands are consistently identified at 13 kDa and 15 kDa across all preparations. This visual provides comparative data on the antigenic profiles and antibody isotype reactivity against somatic and flagellar antigens, relevant for typhoid fever serodiagnosis research.

A diagnostic Western blot (WB) analysis image showing the immunoreactivity of antigens derived from Salmonella typhi and Salmonella spp. The image displays six experimental lanes representing three different protein extraction methods—Whole Cell Protein (WCP), Cell Surface Protein (CSP), and sodium deoxycholate-extracted WCP (sdWCP)—for each bacterial species. A molecular weight (MW) marker lane on the far left, stained with Ponceau S, shows reference bands from 40 kDa to 70 kDa. The WB profile is categorized into three vertical regions: R1 (≥ 55 kDa), R2 (54–34 kDa), and R3 (< 34 kDa). Prominent, high-intensity immunoreactive bands are observed in both species at approximately 70 kDa and 46 kDa, with a noticeable smear in the CSP lanes. Low molecular weight bands are consistently identified at 13 kDa and 15 kDa across all preparations. This visual provides comparative data on the antigenic profiles and antibody isotype reactivity against somatic and flagellar antigens, relevant for typhoid fever serodiagnosis research.

This monochrome clinical photograph captures an intraoperative view of the abdominal cavity during a surgical procedure for bowel perforation. The image illustrates two distinct infectious pathologies concurrently affecting the intestines and peritoneum. Label 'A' identifies a typhoid intestinal perforation, appearing as an irregular, longitudinal breach in the seromuscular layer of the small bowel, typical of advanced Salmonella typhi infection. Label 'B' shows a non-perforated typhoid lesion, characterized by localized inflammation and thickening without a full-thickness defect. Surrounding these intestinal segments, multiple small, discrete, whitish nodules are indicated by label 'C', representing miliary peritoneal tuberculosis. These nodules are scattered across the serosal surfaces and mesentery, demonstrating a grain-like distribution characteristic of disseminated mycobacterial infection. The image serves as a high-level educational example of acute surgical abdomen complications resulting from co-infection of typhoid fever and miliary tuberculosis, highlighting diagnostic landmarks such as transmural perforation and widespread peritoneal seeding.

This monochrome clinical photograph captures an intraoperative view of the abdominal cavity during a surgical procedure for bowel perforation. The image illustrates two distinct infectious pathologies concurrently affecting the intestines and peritoneum. Label 'A' identifies a typhoid intestinal perforation, appearing as an irregular, longitudinal breach in the seromuscular layer of the small bowel, typical of advanced Salmonella typhi infection. Label 'B' shows a non-perforated typhoid lesion, characterized by localized inflammation and thickening without a full-thickness defect. Surrounding these intestinal segments, multiple small, discrete, whitish nodules are indicated by label 'C', representing miliary peritoneal tuberculosis. These nodules are scattered across the serosal surfaces and mesentery, demonstrating a grain-like distribution characteristic of disseminated mycobacterial infection. The image serves as a high-level educational example of acute surgical abdomen complications resulting from co-infection of typhoid fever and miliary tuberculosis, highlighting diagnostic landmarks such as transmural perforation and widespread peritoneal seeding.

This medical illustration depicts anatomical locations and pathological conditions associated with chronic Salmonella Typhi carriage. The graphic is divided into three sections: (A) Gallbladder and liver pathologies, showing Hepatolithiasis, S. Typhi cholecystitis, Cholelithiasis, and Choledocholithiasis, illustrating how stones in the biliary system provide a niche for bacterial persistence. (B) Renal and urinary tract pathologies, highlighting Nephrolithiasis, Ureterolithiasis, Cystolithiasis, and S. Typhi-associated pyelonephritis or cystitis, where urinary stones or abscesses facilitate chronic carriage. (C) Parasitic co-infections, demonstrating how Liver flukes (Clonorchis) and Schistosoma haematobium (showing adults, eggs, and bladder granulomas) predispose patients to chronic infection. The diagram effectively connects infectious disease, pathology, and structural abnormalities of the hepatobiliary and urogenital systems, serving as an educational resource for understanding the reservoirs of chronic typhoid carriers.

This medical illustration depicts anatomical locations and pathological conditions associated with chronic Salmonella Typhi carriage. The graphic is divided into three sections: (A) Gallbladder and liver pathologies, showing Hepatolithiasis, S. Typhi cholecystitis, Cholelithiasis, and Choledocholithiasis, illustrating how stones in the biliary system provide a niche for bacterial persistence. (B) Renal and urinary tract pathologies, highlighting Nephrolithiasis, Ureterolithiasis, Cystolithiasis, and S. Typhi-associated pyelonephritis or cystitis, where urinary stones or abscesses facilitate chronic carriage. (C) Parasitic co-infections, demonstrating how Liver flukes (Clonorchis) and Schistosoma haematobium (showing adults, eggs, and bladder granulomas) predispose patients to chronic infection. The diagram effectively connects infectious disease, pathology, and structural abnormalities of the hepatobiliary and urogenital systems, serving as an educational resource for understanding the reservoirs of chronic typhoid carriers.

Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
I now have enough comprehensive content. Let me compile the full answer.

Typhoid Fever (Enteric Fever)

Definition

Typhoid fever (enteric fever) is a systemic illness caused by Salmonella Typhi (or S. Paratyphi A, B, C). It is characterized by prolonged fever, abdominal pain, and involvement of lymphoid tissue - specifically Peyer's patches of the ileum. The term "typhoid" (Greek: typhus-like) reflects its historical confusion with typhus; "enteric fever" is the preferred modern designation.
  • Harrison's Principles of Internal Medicine, 22nd Ed., p. 1359

Epidemiology

  • 9.2-21 million cases of typhoid fever annually worldwide, causing 110,000-280,000 deaths per year
  • Highest incidence: Indian subcontinent (India, Pakistan, Bangladesh, Nepal), Eastern Mediterranean, and Africa - exceeding 1,000 cases per 100,000 children in some urban areas
  • Affects young children and adolescents disproportionately in endemic regions
  • In the US: ~5,700 cases/year; 78% are travel-associated (predominantly to India, Pakistan, Bangladesh)
  • Humans are the only reservoir - no animal hosts for S. Typhi or S. Paratyphi
  • Harrison's, p. 1359

Pathogen & Transmission

FeatureDetail
OrganismSalmonella enterica serovar Typhi (Gram-negative rod, Enterobacteriaceae)
TransmissionFecal-oral via contaminated food or water; fecal contamination by active cases or chronic carriers
Dose-dependentLarger inoculum = shorter incubation & more severe disease
Risk factorsContaminated drinking water/ice, street vendor food, raw produce fertilized with sewage, lack of hand hygiene, prior H. pylori infection (reduced gastric acidity)
  • Harrison's, p. 1359; Tintinalli's Emergency Medicine, p. 3379

Pathogenesis

  1. Ingestion - organism survives gastric acid and reaches the small intestine
  2. Invasion - penetrates intestinal mucosa at Peyer's patches (ileum)
  3. Lymphatic dissemination - travels to mesenteric lymph nodes
  4. Primary bacteremia - seeding of reticuloendothelial system (liver, spleen, bone marrow)
  5. Secondary bacteremia - massive multiplication in macrophages, re-entry into bloodstream causing the sustained febrile illness
  6. Unlike NTS gastroenteritis (PMN-driven), enteric fever produces mononuclear cell infiltration of the small-bowel mucosa

Clinical Course

Incubation period: 10-14 days (range 5-21 days), depending on inoculum size and host factors

Week-by-Week Progression

WeekFeatures
Week 1Gradual onset fever (38.8-40.5°C), headache (80%), chills (35-45%), cough (30%), myalgias, malaise; relative bradycardia (Faget's sign)
Week 2High sustained fever, rose spots appear (~30% of fair-skinned patients), splenomegaly, abdominal distension, hepatomegaly, coated tongue
Week 3Complications peak: GI bleeding (6%), intestinal perforation (1%), neuropsychiatric features
Week 4Gradual defervescence if untreated; or complications/death

Key Clinical Signs

  • Rose spots - pale pink-red macular rash on the trunk and chest, 2-5 mm, fades in 2-5 days; culturable for S. Typhi; faint and easily missed in dark-skinned patients
  • Relative bradycardia - pulse rate lower than expected for the degree of fever (Faget's sign)
  • "Pea-soup" diarrhea OR constipation (30% present with constipation)
  • "Muttering delirium" / coma vigil - classic neuropsychiatric sign with picking at bedclothes
Typhoid rose spots rash
  • Harrison's, pp. 1360-1361; Tintinalli's, p. 3383

Complications (~27% of hospitalized patients)

Gastrointestinal:
  • Intestinal perforation (1%) and GI bleeding (6%) - occur in 3rd-4th week from ulceration of Peyer's patches; life-threatening, require surgical intervention and broadened antibiotic coverage
  • Hepatitis, pancreatitis, cholecystitis
Typhoid intestinal perforation at laparotomy
Neurological (2-40%):
  • Meningitis, Guillain-Barre syndrome, neuritis, encephalopathy, psychosis, ataxia, seizures, deafness
Other:
  • DIC, hemophagocytic syndrome, myocarditis, pericarditis, endocarditis, osteomyelitis, septic arthritis, glomerulonephritis, hemolytic-uremic syndrome, pneumonia
Chronic carriage:
  • 2-5% develop chronic asymptomatic carriage (shedding >1 year in urine or stool)
  • More common in women, infants, and those with biliary abnormalities or Schistosoma co-infection
  • Associated with increased risk of gallbladder cancer
  • Harrison's, pp. 1360-1361

Diagnosis

Culture (Gold Standard)

SpecimenSensitivityNotes
Blood culture~40-60%Lower yield in week 1; small inoculum (<15 organisms/mL)
Bone marrow culture~80%Best single test; yield maintained even after 5 days of antibiotics
Stool culture30-40% week 1 → positive in week 3+
Combined (blood + BM + duodenal string test)>90%

Serology

  • Widal test - detects agglutinating antibodies to O and H antigens; historically used but poor sensitivity/specificity
  • Typhidot / Tubex - rapid IgM/IgG detection; sensitivity 70-80%, specificity 80-90%; not accurate enough to replace blood culture but useful at point of care

Molecular

  • PCR: sensitivity 40-100% (variable by gene target); increasingly available post-COVID pandemic
  • Harrison's, p. 1361

Treatment

Antibiotic Therapy (Adults)

IndicationFirst-line AgentDose & Duration
Empirical (non-endemic area / susceptible strain)Ciprofloxacin500 mg PO BID or 400 mg IV q12h x 10-14 days
Indian subcontinent / DSC/MDR strainsAzithromycin (mild-moderate)1 g PO day 1, then 500 mg/day x 5-7 days
Severe disease / MDRCeftriaxone2 g IV/IM OD x 10-14 days
Oral optionCefixime400 mg PO BID x 10-14 days (higher clinical failure rate than FQs)
XDR strainsCarbapenems or azithromycin (per susceptibility)
Key 2022 update: A systematic review of 27 RCTs found no significant difference between ceftriaxone, fluoroquinolone, or azithromycin in treatment failure, relapse, or adverse events. However, fluoroquinolones should no longer be used empirically in patients from the Indian subcontinent or Africa due to widespread decreased susceptibility (DSC) strains.
Fluoroquinolone resistance is now a major problem - especially XDR S. Typhi H58 clone from Pakistan (ESBL + plasmid resistance), spreading internationally via air travel.
Dexamethasone (3 mg/kg IV loading, then 1 mg/kg q6h x 48h): reserved for severe typhoid meningitis/encephalitis or septic shock.
Supportive care: IV rehydration, antipyretics, blood transfusion if GI hemorrhage, surgical intervention for perforation.
  • Harrison's, p. 1361; Tintinalli's, p. 3387

Vaccines

VaccineTypeRouteProtectionNotes
Ty21aLive attenuated oralOral (4 capsules)~50-80% for 5-7 yearsAvoid with antibiotics or immunosuppression
Vi-CPS (Typhim Vi)Vi polysaccharide (inactivated)IM injection~50-80% for 2-3 yearsNot effective in children <2 years
Typhbar TCV / TCVTyphoid conjugate vaccine (Vi-TT)IM injection~80%+ for 5+ yearsWHO preferred; effective in children >6 months; WHO SAGE recommended since 2018
  • Vaccines confer only partial immunity - vaccinated travelers must still avoid potentially contaminated food and fluids
  • Revaccination is required since protection wanes
  • Goodman & Gilman's Pharmacological Basis of Therapeutics; Harrison's

Prevention & Control

  1. Sanitation - safe drinking water, sewage treatment, food hygiene
  2. Hand hygiene - especially food handlers
  3. Case management - identify and treat chronic carriers (particularly food handlers); prolonged antibiotics +/- cholecystectomy for biliary carriers
  4. Vaccination - TCV (typhoid conjugate vaccine) campaigns in high-burden countries
  5. Carrier surveillance - 2-5% of patients become chronic carriers; cultures required to confirm clearance
  • Park's Preventive & Social Medicine

Antimicrobial Resistance - Critical Alert

Resistance TypeDrugs Resistant ToOrigin/Spread
MDR S. TyphiChloramphenicol, ampicillin, TMP-SMXEmerged 1980s; now widespread in Asia/Africa
DSC (decreased susceptibility to ciprofloxacin)Ciprofloxacin (MIC ≥0.125 μg/mL)Dominant on Indian subcontinent; ~66% of US travel-imported cases
XDR S. Typhi H58All of above + cephalosporins (ESBL)Emerged Pakistan 2016; spreading globally via air travel; azithromycin is last oral option
Azithromycin resistanceAzithromycinEmerging in multiple countries
  • Harrison's, pp. 1359-1361
Summary: Typhoid remains a major global health threat, particularly on the Indian subcontinent. The emergence of XDR strains has narrowed treatment options dramatically. Blood culture (or bone marrow culture when available) remains the diagnostic gold standard. Azithromycin or ceftriaxone are the current mainstays of treatment; fluoroquinolones should be avoided empirically in travelers from high-prevalence regions. The typhoid conjugate vaccine (TCV) is WHO's preferred preventive tool.
This is a shared conversation. Sign in to Orris to start your own chat.